Results 101 to 110 of about 729,060 (268)

Gradient boosting model optimized by the certainty factor method to landslide susceptibility assessment

open access: yesShuiwen dizhi gongcheng dizhi
The gradient boosting model (GBM) has demonstrated strong predictive performance in landslide susceptibility assessment; however, the complexity of factors limits its stability and accuracy.
Fei WANG   +5 more
doaj   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

UAV Remote Sensing for Integrated Monitoring and Model Optimization of Citrus Leaf Water Content and Chlorophyll

open access: yesAgriculture
Leaf water content (LWC) and chlorophyll content (CHL) are pivotal physiological indicators for assessing citrus growth and stress responses. However, conventional measurement techniques—such as fresh-to-dry weight ratio and spectrophotometry—are ...
Weiqi Zhang   +6 more
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Accurate prediction of kiwifruit soluble solids content using an optimized 1D-CNN model with near-infrared spectroscopy

open access: yesInternational Journal of Food Properties
With the growing demand for ready-to-eat kiwifruit in the world, consumers are placing higher demands on the edible quality of kiwifruit, particularly its soluble solids content (SSC), which determines its flavor and internal quality.
Wei Geng   +5 more
doaj   +1 more source

RECOVER identifies synergistic drug combinations in vitro through sequential model optimization. [PDF]

open access: yesCell Rep Methods, 2023
Bertin P   +19 more
europepmc   +1 more source

Clinical performance of the urine‐based TERT promoter AbsoluteQ Digital PCR for non‐invasive detection of bladder cancer

open access: yesMolecular Oncology, EarlyView.
A urine‐based digital PCR assay targeting two hotspot TERT promoter variants detected bladder cancer with high sensitivity and no false positives in this case–control cohort. The streamlined AbsoluteQ workflow outperformed Sanger sequencing and supports non‐invasive molecular testing for bladder cancer detection.
Anna Nykel   +12 more
wiley   +1 more source

Intelligent Edge Computing and Machine Learning: A Survey of Optimization and Applications

open access: yesFuture Internet
Intelligent edge machine learning has emerged as a paradigm for deploying smart applications across resource-constrained devices in next-generation network infrastructures.
Sebastián A. Cajas Ordóñez   +3 more
doaj   +1 more source

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy